Bjøro K, Schrumpf E, Elgjo K, Nordgård K
Medisinsk avdeling A, Rikshospitalet, Oslo.
Tidsskr Nor Laegeforen. 1990 Apr 30;110(11):1346-8.
Non-A non-B hepatitis remains a diagnostic and therapeutic problem. Recently published data indicate that interferon may represent a considerable step forward in the therapy of this disease. We have treated a patient with non-A non-B hepatitis with recombinant interferon alpha 2-B. Both biochemical and morphological liver parameters were normalized after nine months of treatment. Further studies are being performed to establish the efficacy and effective doses of interferon in the treatment of non-A non-B hepatitis.
非甲非乙型肝炎仍然是一个诊断和治疗难题。最近发表的数据表明，干扰素可能是治疗这种疾病的一个重大进展。我们用重组干扰素α2 - B治疗了一名非甲非乙型肝炎患者。经过九个月的治疗，肝脏的生化和形态学指标均恢复正常。目前正在进行进一步研究，以确定干扰素治疗非甲非乙型肝炎的疗效和有效剂量。
